Turkey
Matriks Biyotek, founded in 2002, is a Turkey-based medical biotechnology company. Led by Prof. Haluk Ataoglu MD, PhD, the company specializes in life sciences and medical biotechnology, with a global presence. Celebrating its 20th anniversary in 2022, Matriks Biotek is known for being the first company worldwide to produce and commercialize SHIKARI® Biological Drug Monitoring Kits, a range comprising 100 SHIKARI® ELISA kits for 36 biological drugs and 16 CoronaHunter® ELISA kits for Covid-19 antibodies determination.
The company's dedication to research and development is evident with over 170 publications utilizing their products. With a focus on quality management, their production adheres to ISO 13485:2016 standards, and all products hold the CE-IVD mark for the European market. Notably, Matriks Biotek boasts a technical support response time and a complaint rate of under 0.5%.
While specific details about the latest investment are currently undisclosed, the company positions itself as a significant player in the biotechnology and pharmaceutical industries, offering a wide range of innovative and quality products valued by the medical community globally.
To learn more about their offerings or to request a quotation, interested parties can contact Matriks Biotek via [email protected] or visit their website at www.matriksbiotek.com. Connect with them on LinkedIn at https://www.linkedin.com/company/matriks-biotechnology-co-/.
